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Abstract
Heparan sulfate (HS) proteoglycans represent a major component of the extracellular matrix and are critical for brain
development. However, their function in the mature brain remains to be characterized. Here, acute enzymatic digestion of HS
side chains was used to uncover how HSs support hippocampal function in vitro and in vivo. We found that long-term
potentiation (LTP) of synaptic transmission at CA3–CA1 Schaffer collateral synapses was impaired after removal of highly
sulfated HSs with heparinase 1. This reduction was associated with decreased Ca2+ inﬂux during LTP induction, which was the
consequence of a reduced excitability of CA1 pyramidal neurons. At the subcellular level, heparinase treatment resulted in
reorganization of the distal axon initial segment, as detected by a reduction in ankyrin G expression. In vivo, digestion of HSs
impaired context discrimination in a fear conditioning paradigm and oscillatory network activity in the low theta band after
fear conditioning. Thus, HSs maintain neuronal excitability and, as a consequence, support synaptic plasticity and learning.
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Introduction
Heparan sulfate proteoglycans (HSPG) are present throughout
the brain and are located on cell membranes but also in the
extracellular matrix (ECM). HSPGs represent a heterogeneous
group of proteins, among them the ECM molecules agrin and
perlecan as well as cell surface molecules like syndecans and
glypicans (Sarrazin et al. 2011). A common feature of HSPGs is
covalently bound side chains of heparan sulfates (HSs), which
are often the sites of interactions with ligands such as growth
factors (Sarrazin et al. 2011; Matsuo and Kimura-Yoshida 2014).
These HSs are unbranched polysaccharides that are synthe-
sized from N-glucuronic acid and N-acetylglucosamine before
extensive modiﬁcation by, for instance, sulfation. HSPGs play a
well-established role during brain development. They are im-
portant for patterning of the brain, neurogenesis and crucial for
axonal guidance (Yamaguchi et al. 2010). Consequently, most
studies of HSPGs have focused on developmental aspects of
HSPG signaling.
In addition, HSPGs can profoundly modulate memory and
learning in adult animals and synaptic long-term plasticity in
acute slices prepared from these (Senkov et al. 2014). Interest-
ingly, a recent study demonstrated that conditional ablation of
Ext1, a gene involved in HS synthesis, from a subpopulation of
pyramidal neurons leads to an autistic phenotype (Irie et al. 2012).
These ﬁndings indicate that HSPGs and HSs shape brain function
onmany levels from cellular properties to complex behavior.
However, both a developmental phenotype and the acute
absence of the HSPGs or HSs may underlie such a deﬁcit in the
adult. Acute enzymatic digestion of ECM components has been
used to identify speciﬁc roles of ECM components and to isolate
their acute contribution to adult brain functions (Senkov et al.
2014). For example, enzymatic digestion of hyaluronic acid in
intact brain tissue can be achieved within only 2 h
(Kochlamazashvili et al. 2010), thus avoiding potential develop-
mental side effects of genetic manipulations. Similar to hyalur-
onic acid, the function of HSs has been studied mainly by
either genetic ablation of the HS bearing proteoglycans or
enzymatic digestion of HS side chains. In dissociated hippo-
campal cultures, enzymatic removal of highly sulfated HSs
with heparinase 1 affects synaptic scaling and decreases the
mean ﬁring rate of neurons (Korotchenko et al. 2014; Garau
et al. 2015). In acute hippocampal slices, treatment with a com-
bination of heparinases 1 and 3, which supposedly removes
both low and highly sulfated HSs, impairs long-term potenti-
ation (LTP) of synaptic transmission (Lauri et al. 1999; Dityatev
et al. 2004). However, the type of involved HSs and the cellular
and network mechanisms underlying this LTP impairment
have remained unclear. In addition, it is mostly unknown how
HSs acutely affect behavior or network activity in vivo.
Here, we addressed these open questions by a combination
of electrophysiological, imaging, and behavioral experiments.
Our results in vitro show that removal of highly sulfated HSs
reduces CA1 pyramidal cell excitability, which in turn leads to
decreased dendritic and spine Ca2+ entry and impaired LTP. In
vivo, the reduced excitability is associated with altered oscilla-
tory network activity in the low theta range and abolished con-
textual discrimination in a fear conditioning paradigm.
Materials and Methods
Slice Preparation and Heparinase Treatment
Acute hippocampal slices were prepared from 5 to 8-week-old
male C57BL/6 mice and Thy1-YFP (Feng et al. 2000) mice as
previously described (Kochlamazashvili et al. 2010; Anders
et al. 2014). Brieﬂy, acute hippocampal slices were obtained in
full compliance with national and institutional guidelines on
animal experimentation. Slices, 350 µm thick unless stated other-
wise, were prepared in an ice-cold slicing solution containing (in
mM): NaCl 60, sucrose 105, KCl 2.5, MgCl2 7, NaH2PO4 1.25, ascor-
bic acid 1.3, sodium pyruvate 3, NaHCO3 26, CaCl2 0.5, and glu-
cose 10 (osmolarity 300–305mOsm), and kept in the slicing
solution at 34 °C for 15min before being stored at room tempera-
ture (RT, 21–23 °C) in an extracellular solution containing (in
mM) NaCl 126, KCl 2.5, MgSO4 1.3, NaH2PO4 1.25, NaHCO3 26,
CaCl2 2, and glucose 10. This solution was also used for record-
ings at RT. Heparinase 1 from Flavobacterium heparinum (Sigma
H2519, 1 U/mL) was used for enzymatic removal of HSs from hip-
pocampal slices in custom-made aerated incubation chambers
(2mL volume, at 34 °C). For sham treatment, a subset of hepari-
nase aliquots was heat-inactivated for 120min at 60 °C. All solu-
tions were continuously bubbled with 95% O2/5% CO2.
In Vitro Electrophysiology
For recordings, hippocampal slices were transferred to a
submersion-type recording chamber and superfused with extra-
cellular solution at RT. For extracellular recordings, standard
patch pipettes (3–4MΩ) were ﬁlled with extracellular solution and
inserted into the CA1 stratum radiatum. Whole-cell recordings
fromCA1 pyramidal cellswere obtained using standard patch pip-
ettes (3–4MΩ) ﬁlled with an intracellular solution containing (in
mM) KCH3O3S 135, HEPES 10, di-Tris-Phosphocreatine 10, MgCl2 4,
Na2-ATP 4, Na-GTP 0.4 (pH adjusted to 7.2 using KOH, osmolarity
290–295mOsm). Membrane-impermeable dyes Oregon Green 488
BAPTA-1 (OGB1, 200 µM, Invitrogen), OGB6F (250 µM), Fluo-4
(200 µM), and Alexa Fluor 594 hydrazide (20 µM, Invitrogen) were
added to the intracellular solution as indicated. In a subset of
recordings, KCH3O3S was replaced by equimolar CsCH3O3S. Data
were recorded using MultiClamp 700B ampliﬁers, digitized (10–
40 kHz) and stored for ofﬂine analysis. Whole-cell recordings were
rejected if at any time the access resistance exceeded 20MΩ or
changed by more than 20%. Bridge balance and series resistance
compensation was used as appropriate. For stimulation experi-
ments, a bipolar concentric stimulation electrode was placed in
the “stratum radiatum” at the border between CA2/3 and CA1. For
theta-burst stimulations (TBS), 8 bursts consisting of 4 stimuli
(0.1ms each, 100Hz) were delivered at 5Hz (a single TBS cycle).
The pattern was repeated up to 5 times (5x TBS) with an interval
of 1min between individual TBSs. For LTP experiments presented
in Figure 1, the stimulation intensity was adjusted to obtain ﬁeld
excitatory postsynaptic potentials (fEPSPs) with a slope of 50% of
the subthreshold maximum (subthreshold maximum: fastest-
rising fEPSP without a clearly visible population spike in the decay
phase) (Kochlamazashvili et al. 2010). For experiments presented
in Figures 2 and 4, the stimulus intensity was set to 4 times the
intensity needed to elicit a single action potential by a single test
burst of 5 stimuli at 100Hz to compensate for variable stimulation
efﬁciencies between slices (Kochlamazashvili et al. 2010). In some
experiments, N-methyl-D-aspartate receptor (NMDAR)-mediated
fEPSPs were recorded in the presence of 0.1mMMg2+ and isolated
pharmacologically by the α-amino-3-hydroxy-5-methyl-4-isoxa-
zolepropionic acid receptor (AMPAR)-inhibitor NBQX. In these
experiments, a cut wasmade between CA3 and CA1.
Characterization of current clamp data was performed using
custom written Matlab (Mathworks) scripts previously
described (Heeroma et al. 2009). For analysis of data in Figure 4e
and Supplementary Figure 6, values were averaged over all 5
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current injection cycles after 4-way ANOVA had indicated that
the cycle is not a signiﬁcant factor.
Channel or receptor blockers D-AP5 (50 µM, Abcam), NBQX
disodium salt (10 µM, Abcam), CGP52432 (5 µM, Abcam), nifedi-
pine (20 µM, Sigma-Aldrich), picrotoxin (PTX, 100 µM, Abcam),
and tetrodotoxin (TTX, 1 µM, Tocris) were added to the extracel-
lular solution as indicated.
Immunocytochemistry and Immunohistochemistry
Mouse hippocampal neurons were cultured for 24 days in vitro
and incubated with 0.5 U/mL of heparinase 1 for 2 h at 37 °C as
described previously with some modiﬁcations (Dityatev et al,
2004) and ﬁxed with 4% paraformaldehyde (PFA), permeabilized
with 0.1% Triton-X-100 in phosphate-buffered saline (PBS) for
10min, washed 3 times and blocked (0.1% Glycine + 0.1% Tween-
20 + 10% Normal Goat Serum in PBS) for 45min at RT. Anti-HS
antibody A04B08V (dilution 1:2; the antibody was puriﬁed against
mouse skeletal muscle HS and supposed to recognize 2-O and
6-O high sulfate group) (Dam et al. 2003) diluted in blocking buffer
was applied for overnight followed by 3 washes with PBS.
Incubation with secondary antibody (anti-VSV-G, clone P5D4,
dilution 1:100) and tertiary antibody (Mouse, Alexa 488, dilution
1:1000) was carried out for 3 and 1h, respectively. Coverslips
were subsequently washed with PBS, incubated with DAPI
(Invitrogen, reference number-D1306) for 10min and mounted
using ﬂuoromount aqueous mounting media (Sigma-F4680). For
hippocampal sections, the similar procedure was applied but per-
meabilization step was carried out with 0.5% Triton-X-100 in PBS
for 10min and anti-VSV-G, clone P5D4 antibody was used with
the dilution 1:50.
For ankyrin G (AnkG) labeling, acute horizontal hippocampal
slices (250 µm thick) of three 52–58-day-old Thy1-YFP animals
(Feng et al. 2000) were prepared and treated with heparinase as
described above. After heparinase/control incubation, the slices
were immersion-ﬁxed in 4% PFA in PBS (pH 7.4) at 4 °C for 2 h.
Next, slices were washed for 3 × 30min in PBS before incubation
in a blocking solution (5% normal goat serum and 0.1% Triton-X-
100 in PBS) at RT for 6 h. Primary antibodies against GFP (host:
chicken, 1:5000, Abcam, ab13970) and AnkG (mouse monoclonal,
1:500, Neuromab, clone N106/36) were incubated in blocking
solution at 4 °C for 40h. After a 3 × 30min PBS wash, secondary
antibodies (goat antichicken Alexa Fluor 488, goat antimouse
Alexa Fluor 568, both 1:200, Invitrogen) were incubated at RT for
2 h. Slices were again washed 3 × 30min in PBS before being
mounted with ProLong Gold Antifade (Invitrogen). Imaging was
performed on a Leica SP8 confocal microscope with a glycerol
immersion 63x, 1.3 NA objective and hybrid detectors. Initial
image analysis was done by an experimenter blinded to the
experimental conditions using ImageJ (NIH) and Microsoft Excel.
CA1 pyramidal cell axon initial segments (AISs) were identiﬁed
using the YFP-label and their typical morphology and conﬁrmed
by AnkG labeling. Axonal AnkG expression proﬁles were obta-
ined from image stacks by average intensity projections of all
Figure 1. Removal of HSs impairs LTP of synaptic transmission at CA3–CA1 Schaffer collateral synapses in acute hippocampal slices. (a, b) Schematic recording conﬁg-
uration. fEPSPs were recorded in the stratum radiatum of the CA1 region and evoked by electrical stimulation of CA3–CA1 Schaffer collaterals. Sample fEPSPs recorded
from control and heparinase-treated slices (blue and red, respectively, left panel). fEPSP slopes normalized to the axonal ﬁber volley were virtually indistinguishable
between control and heparinase-treated slices (n = 9 both groups, middle panel). Stimulation intensity for bar graphs was 100 µA (please see Supplementary Fig. 2a–c
for the complete range of stimulus intensities tested, ﬁber volleys and slopes before normalization and statistics). NMDAR-mediated fEPSPs were recorded in the pres-
ence of 0.1mM Mg2+ and the AMPAR-inhibitor NBQX and were not signiﬁcantly different between control and heparinase-treated slices (right panel, n = 6 both
groups, please see Supplementary Fig. 2d for complete range of stimulus intensities and statistics). (c) The fEPSP paired-pulse ratio was not different between control
and heparinase-treated slices (n = 9 both). The interstimulus interval was 50ms (please see Supplementary Fig. 2d,e for sample traces, the complete range of intervals
tested and statistics). (d) LTP was induced by TBS. Sample traces before (solid lines) and after LTP induction (dotted lines) are shown for control- and heparinase-
treated slices (left panel, blue and red, respectively). Time courses of fEPSP slopes in LTP experiments are shown in the right panel (n = 8 both groups, 5 TBS cycles).
(e) LTP induced by a single TBS is not affected by removal of HSs (1× TBS, n = 8 both groups, P = 0.267, unpaired t-test). In contrast, strong LTP-inducing stimuli
(5 cycles of TBS, n = 8 both groups, P = 0.0024, unpaired t-test) uncovered an LTP deﬁcit in heparinase-treated slices. The effect persisted in the presence of the GABA
receptor antagonist PTX (100 µM, n = 8 and 7 for control and heparinase-treated slices, P = 0.023, unpaired t-test).
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imaging planes containing AnkG signal (max stack z-depth
5 µm). A line proﬁle was then drawn along the AIS starting from
the center of the soma and ﬁnishing just beyond the most distal
AnkG signal (typically 40–45 µm from the soma). Further details
are provided in Figure 5 and the corresponding Results section.
For AnkG labeling in dissociated cultures, mouse hippocam-
pal cultures were treated with heparinase and heat-inactivated
heparinase (control) as described above after 21 days in vitro
(DIV21). Subsequently, cells were quickly rinsed with warm PBS
and subjected to above-mentioned immunocytochemistry pro-
tocol to stain with antibodies against AnkG (mouse monoclo-
nal, 1:1000) and MAP2 (guinea pig, 1:500). Imaging was
performed with the experimenter blinded to the experimental
groups on a Zeiss LSM 700 confocal microscope with a 63x/1.4
NA oil immersion objective. Image analysis was done using
ImageJ (NIH) and Microsoft Excel. AISs were detected as AnkG
positive immunoﬂuorescence starting from the edge of the
soma as deﬁned by MAP2 positive immunostaining. Of note,
40 µm long ﬂuorescence intensity line proﬁles were taken along
the AIS starting from the edge of the soma.
In Vivo Electrophysiology, Intrahippocampal Injection
and Behavioral Testing
Animals
Adult (2–4-month old) male C57BL/6 J mice (Charles River) were
used. At least 1 week before start of the experiments, mice
were transferred to a small vivarium, where they were housed
individually with food and water ad libitum on a reversed 12:12
light/dark cycle (light on at 9:00 PM). All behavioral experiments
were performed in the afternoons during the dark phase of
the cycle when mice are active, under constant temperature
(22 ± 1 °C) and humidity (55 ± 5%). All treatments and behav-
ioral procedures were conducted in accordance with ethical
animal research standards deﬁned by German law and appr-
oved by the Ethical Committee on Animal Health and Care of
the State of Saxony-Anhalt, Germany, the licence number
42502-2-1159 DZNE.
Fabrication of Electrodes and Cannulas
We have used a previously described hybrid infusion-
multielectrode (HIME) recording system for acute drug delivery
at the place of acquisition of neuronal activity (Senkov et al.
2015). In short, a 5 electrodes bundle was made of tungsten wires
insulated with Teﬂon and bound together in a stainless steel tub-
ing. Electrode tips were arranged to aim to different major hippo-
campal layers, using a decrement of 250 μm between each
electrode, starting from 2mm length, to reach molecular layer of
the dentate gyrus (DG), and ending with the shortest electrode,
1–1.1mm, to record from stratum oriens and pyramidale. For fabri-
cation of guide cannulas, we used the same stainless steel tubing
as for electrodes.
Implantation of Electrodes and Cannulas
Chronic implantation of electrodes and cannulas in mice was
performed as described previously (Kochlamazashvili et al.
2010; Senkov et al. 2015) (see Fig. 7a for a schematic of electrode
and cannula placement). In brief, mice were anesthetized with
Figure 2. Ca2+ entry at spines and dendrites of CA1 pyramidal cells during TBS
is reduced in heparinase-treated hippocampal slices. (a) CA1 pyramidal cells
were held in the whole-cell patch-clamp conﬁguration and ﬁlled via the patch
pipette with the Ca2+-sensitive ﬂuorescent dye Fluo-4 (200 µM) and the morpho-
logical marker Alexa Fluor 594 (20 µM). Dendrites and synaptic spines were
visualized using 2PE ﬂuorescence microscopy (excitation wavelength 800 nm).
Positions of line scans across dendrites and spines were pseudo-randomly cho-
sen (inset, position of line scan indicated by dashed line, 0.4–0.8 kHz). (b)
Fluorescence changes were monitored (line scans, a) during TBS (top panel,
stimulus pattern) while neurons were recorded from in current clamp mode
(middle panel). Representative line scans of Fluo-4 ﬂuorescence from sham and
heparinase-treated slices are shown in the bottom panel (average of 5 TBS). (c)
Global averages of Fluo-4 ﬂuorescence traces reveal reduced Ca2+ entry in
heparinase-treated slices (n = 10 and 11 for control and heparinase treatment).
(d) Ca2+ entry was quantiﬁed by calculating ΔF/F0 (see Materials and Methods
for details) for each burst and corrected for decaying ﬂuorescence from the
previous burst. Lower values of ΔF/F0 in heparinase-treated cells indicate a
reduced Ca2+ entry during TBS after removal of HSs (2-way repeated measures
ANOVA, P = 0.021, unpaired t-tests for individual bursts). Illustrated experi-
ments were performed in the presence of AP5 (see text for further details).
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1–3% isoﬂurane (Baxter International, Inc.). Preparation for
implantation included injection and application of analgesics,
head hair shaving, and skin cleaning and application of an anti-
septic as previously described (Senkov et al. 2015) before the
mouse was placed in a stereotaxic frame (Narishige). All follow-
ing procedures were performed under a surgical binocular
microscope and on a heating pad to maintain mouse body tem-
perature constant (34–36 °C) over surgery. A 10mm diameter
circular scalp incision was done and exposed skull bone was
cleaned and dried. After marking coordinates for implantation,
3 small holes for anchoring and ground screws were drilled in
2 frontal bones and one in the left parietal at the border with
the interparietal bone. Two frontal screws and a parietal screw
were connected with a ground/reference wire. The left cannula
was stereotactically implanted after drilling another hole and by
using a self-made universal holder and ﬁxed using acrylic. Next,
hippocampal electrodes were implanted in the right parietal
bone. After hippocampal electrodes, the right cannula was simi-
larly implanted and secured with acrylic. Coordinates for bilat-
eral cannulas: AP = 2.0mm and L = ±2.2mm from Bregma and
midline, respectively. Coordinates for the 5 electrodes bundle
reaching different layers of the hippocampus were: AP =
−2.0mm from Bregma and L = ±1.25mm; DV = 2.0mm from the
brain surface. The whole system was secured to the bone with
dental cement and the Neuralynx EIB-16 headstage was screwed
into position. Finally, tungsten wire tails from electrodes were
gently connected to the headstage. After the assembly was com-
pleted, all ground wires were soldered together and the upper
cover “hat” as a Faraday cage was placed above the bottom ped-
estal and ﬁxed to it with 2 small screws. Surgery typically lasted
90min. Mice were allowed to recover for at least 5–7 days before
behavioral test and recordings (postoperative analgesic: carpro-
fen, 5mg/kg b.w. s.c.).
Intrahippocampal Injection
For intrahippocampal injection, we used a digitally controlled
infusion system (UltraMicroPump, UMP3, and Micro4 Controller,
WPI) fed with a 10 μL Hamilton syringe and a NanoFil (35 GA)
bevelled needle. The mouse was ﬁrst anesthetized with 1–3% iso-
ﬂurane and put into the stereotaxic frame. The headstage EIB-16
was then gently unscrewed and shifted to expose underneath
electrodes and cannulas. The dummy cannula was gently
removed from the left guide cannula before the NanoFil injecting
needle was inserted into the guide cannula and active hepari-
nase 1 (0.05U/1 μL per site, Sigma-Aldrich) or, as control treat-
ment, heat-inactivated heparinase 1 (30min boiling in 100 °C)
was injected at a rate of 3 nL/s. After waiting for another 5min,
the injection needle was replaced by the dummy and the same
procedure was performed on the other hemisphere. The dur-
ation of the procedure including re-mounting of the headstage
after injection was about 25–30min.
Fear Conditioning
A classical Pavlovian contextual fear conditioning (CFC) para-
digm was used. In short, CFC was done at day 0 (d0) as follows:
1 day after intrahippocampal injections, mice were placed in a
neutral context (CC−) for 5min to record behavior and electro-
encephalography (EEG). 1–2 h later the same mice were placed
into a conditioned context (CC+) for 5min and 3x medium
Figure 3. Ca2+ entry induced by b-APs or direct depolarization is not affected by
heparinase treatment. (a) Pyramidal cells were held in whole-cell voltage clamp
at −70mV and ﬁlled via the patch pipette with the Ca2+-sensitive ﬂuorescent
dye Fluo-4 (200 µM) and the morphological marker Alexa Fluor 594 (20 µM).
Dendrites and synaptic spines were visualized using 2PE ﬂuorescence micros-
copy at 800 nm. Position of line scans across dendrites and spines was pseudo-
randomly chosen (inset, position of line scan indicated by dashed line, 0.4–
0.8 kHz). b-APs were evoked by brief (2–3ms) voltage jumps to +10mV (2–3ms
each, 5 at 20Hz, sample trace with clipped action currents in bottom panel).
Fluo-4 ﬂuorescence line proﬁles indicate robust Ca2+ entry in response to b-APs
while Alexa Fluor 594 ﬂuorescence remains stable. (b, c) Time courses of Fluo-4
ﬂuorescence during b-APs trains in control and heparinase-treated slices. No
signiﬁcant differences could be detected (n = 16 and 25 for sham and hepari-
nase treatment, respectively, 2-way repeated measures ANOVA, P = 0.96). (d)
Ca2+ entry in response to direct, AP-independent depolarization was investi-
gated by FLIM in cells ﬁlled with the Ca2+-sensitive ﬂuorescent dye Oregon
Green BAPTA-1 (OGB1, 200 µM, please see Supplementary Fig. 3 and text for fur-
ther details). Ca2+ responses were evoked by brief voltage steps from −70 to
+20mV for 25ms (3× at 1 Hz) in the presence of TTX (1 µM). OGB1 lifetimes were
translated into Ca2+ concentrations and their time courses were plotted. No
signiﬁcant difference was detected between control and heparinase-treated
spines and dendrites (n = 13 for control spines, all other n = 12, amplitudes 2-
way repeated measures ANOVA, P = 0.39 for dendrites and 0.55 for spines).
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intensity foot shocks were applied (0.5mA, 1 s) with an interval
of 1min. The protocol was 2min exploration of CC+, then ﬁrst
shock, after 1min second shock, and again after 1min the third
shock, mice were then given another minute in CC+ before
being removed. EEG was not recorded during the training. The
conditioned context (CC+) was a chamber (20×20×30 cm) with
contrast black-and-white chess-like pattern on the walls and a
metal grid on the ﬂoor (75% ethanol was used for cleaning). The
neutral context (CC−) was the same chamber, but with gray
walls and gray plastic ﬂoor, and another type of cleaning solu-
tion was used with a different smell. On d1 and d3, the mice
were subjected to retrieval sessions. First, mice were placed
in CC+ for 5 min and then 1–2 h later they were placed into
CC− context for 5min. All tests were recorded with video syn-
chronized with EEG. For CFC, we used a computerized fear con-
ditioning system (Ugo Basile). The behavior of mice during fear
conditioning was recorded for ofﬂine analysis using an USB
video camera and a behavioral video acquisition and analysis
software (AnyMaze). All recorded movies were analyzed by a
trained observer blinded to the treatment group. Total freezing
time was calculated as the percentage of 5min (in either of the
2 contexts, CC+ and CC−).
LFP Recordings
Intrahippocampal local ﬁeld potentials (LFPs) were recorded by
using a 64 channels recording system and the acquisition
Figure 4. CA1 pyramidal cells generate fewer action potentials during TBS and TBS-like current injections after heparinase treatment. (a, b) Representative current
clamp recordings from CA1 pyramidal cells during synaptic TBS from control (blue, top) and heparinase (red, middle panel) treated slices (stimulation pattern, bottom
panel). Note the reduced number of action potentials generated during individual bursts after heparinase treatment. The number of spikes was analyzed for each
burst, averaged over 5 TBS cycles and found to be lower in heparinase-treated neurons (2-way repeated measures ANOVA, P = 0.003, n = 5 for control slices and 7 for
heparinase-treated slices). (c, d) Current injections with a TBS-like pattern (40ms, 8 times at 5 Hz, 5 cycles as in a, b) evoked fewer action potentials in CA1 pyramidal
cells from heparinase-treated slices (2-way repeated measures ANOVA, P = 0.040, n = 13 and 12 for control and heparinase-treated slices, unpaired t-tests for individ-
ual bursts). This suggests that reduced neuronal excitability may underlie deﬁcits of Ca2+ inﬂux and LTP. (e) The threshold of spikes evoked by TBS-like current injec-
tions was progressively increased after heparinase treatment. While no effect was observed on the ﬁrst spike in each burst (2-way repeated measures ANOVA, P =
0.239) the threshold of the second spike was increased during repetitive stimulation (2-way repeated measures ANOVA, P = 0.031, unpaired t-tests for individual
bursts; ﬁrst and second spike, ﬁlled and empty circles; color coding as above, n = 13 for control and n = 13 and 12 for ﬁrst spikes and 13 and 10 for second spikes). (f) A
qualitatively similar increase of spike thresholds was unmasked when spiking was evoked by constant current injections of increasing intensity in the current clamp
conﬁguration (same color coding as in e, sample traces and current injection left panel, statistics right panel, n = 10 for control and 8 for heparinase treatment, 2-way
repeated measures ANOVA, P = 0.043 and 0.030, unpaired t-tests).
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software Cheetah (both Neuralynx). LFPs were recorded at
3200Hz sampling rate, a 0.1–300Hz wide-band ﬁlter, ×1000
ampliﬁcation, and stored for ofﬂine analysis. LFPs were ana-
lyzed using NeuroExplorer (5.0, Madison). To record from a
freely moving mouse, we used a 5m cable (Neuralynx) counter-
balanced with an equal weight of the headstage and the cable
itself. For further data analysis, we chose 2 electrodes targeting
2 most interesting structures (CA1 and DG) involved in context-
ual memory and contextual discrimination, and electrodes
were selected based on following criteria: 1) length of electro-
des; 2) histology depicting electrode traces (Fig. 6b); 3) lowest
theta power is characteristic for CA1 stratum pyramidale,
whereas highest theta power for molecular layer of DG (Fig. 6c);
4) high-frequency oscillations as ripples are characteristic for
stratum pyramidale and/or radiatum.
Two-Photon Excitation (2PE) Ca2+ Imaging
CA1 pyramidal cells, their dendrites, and spines were visua-
lized by 2-photon excitation (2PE) ﬂuorescence microscopy. We
used a Scientiﬁca system (Scientiﬁca) and a FV10MP imaging
system (Olympus) optically linked to a femtosecond pulse laser
(Vision S, Coherent, λ = 800 nm) both integrated with patch-
clamp electrophysiology (Multiclamp 700B, Molecular Devices)
(Kochlamazashvili et al. 2010; Henneberger and Rusakov 2012;
Anders et al. 2014). Setups were equipped with 25× (NA 1.05)
and 40× (NA 0.8) objectives (Olympus). The laser power was
adjusted for depth in the tissue to obtain, on average, 2–3mW
in the focal plane. Fluorescent dyes were loaded via the whole-
cell patch-clamp pipette. Once in whole-cell mode, Alexa Fluor
594 typically equilibrated across the neuron within 10–15min
and was used to visualize dendrites and spines. For ﬂuores-
cence recordings from spines and dendrites, a region of interest
was pseudo-randomly chosen. Rapid scans across a line cover-
ing spines and dendrites were performed (line scans, 0.4–
0.8 kHz) synchronized to electrophysiology. After background
correction, ﬂuorescence intensity (F) or its changes (ΔF) were
normalized to the baseline ﬂuorescence (F0) before any stimulus
to obtain F/F0 or ΔF/F0. In analyses presented in Figures 2d and 3c
peak F/F0 or ΔF/F0 values were corrected for decaying ﬂuorescence
from the previous stimulus (Kochlamazashvili et al. 2010). The
decay time constant of Ca2+-dependent ﬂuorescence did not dif-
fer between sham and heparinase-treated slices (monoex-
ponential ﬁt, sham 161.9 ± 13.0ms, heparinase 137.1 ± 15.8ms,
Figure 5. AnkG expression is reduced in the distal AIS after heparinase treatment. (a) Mice expressing the ﬂuorescent protein YFP (green) under the Thy1 promoter
(Feng et al. 2000) were used to identify CA1 pyramidal cells and their presumptive AISs. The AIS was visualized by colabeling with a mouse anti AnkG antiserum
(magenta). (b) Sample AnkG labeling of an AIS from a heparinase-treated slice (top panel magniﬁed from a, dashed box) and a control slice (middle panel). AnkG label-
ing in dissociated cultures (see Supplementary Fig. 8 and Results) predicted a distal reduction of ASI AnkG labeling after heparinase treatment. Therefore, the axonal
AnkG distribution was determined by taking a line proﬁle (width = 0.57 µm) along the AIS starting from the center of the pyramidal cell soma. The background-
corrected AnkG proﬁles of the examples are shown in the bottom panel (blue control, red heparinase). (c) To avoid distorted AnkG proﬁles due to the large variability
of the AIS start (see Results and Supplementary Fig. 9), we selected only axonal AnkG proﬁles where the AIS started within mean ± 3 × SEM for further analysis. The
average ﬂuorescence intensity proﬁles are shown (n = 17 for control and 21 for heparinase-treated slices). Note that distance is given relative to the soma center in
these plots. (d) The average background-corrected AnkG signal in the distal AIS (30–40 µm from the soma center) was reduced in heparinase-treated slices (P = 0.0019,
unpaired t-test). (e) A similar result was obtained when axonal AnkG proﬁles were normalized to values obtained near the axonal hillock to account for variability of
excitation and detection of the ﬂuorescent label (P = 0.00049, unpaired t-test).
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n = 29 and 17, unpaired t-test, P = 0.354). For recording of Ca2+
transients, the membrane potential was adjusted to −70mV
(either in voltage clamp or via a constant holding current). For
Schaffer collateral stimulation (5× TBS; see above, Fig. 2), the
stimulus intensity was set to 4× the intensity to induce a single
action potential in a burst. The NMDAR inhibitor AP5 (50 µM) was
added in these experiments to prevent Ca2+ indicator saturation
and to reduce variability (a modulation of NMDAR-mediated syn-
aptic transmission by heparinase treatment has been excluded,
as shown in Fig. 1b and Supplementary Fig. 2d). Ca2+ responses to
back-propagating action potentials (b-AP) were evoked by 2–3ms
long command jumps to +10mV at a frequency of 20Hz (Fig. 3).
In a subset of experiments, saturation of the Ca2+ indicator Fluo-4
was induced using a high-frequency train of 80 bAPs at 100Hz.
Resting [Ca2+] was estimated from the ratio F0/FMAX (see
Supplementary Fig. 5a–c) (Ermolyuk et al. 2012). The low-afﬁnity
Ca2+ indicator OGB6F was used in a Cs+-based intracellular solu-
tion (see above) to measure the nifedipine-sensitive component
of sustained Ca2+ inﬂux into dendrites and spines during 1 s of
depolarization from −50 to +20mV in presence of TTX, NBQX,
AP5, PTX, and CGP52432 (see Supplementary Fig. 4). Line scans
were repeated for up to 10 times for each region of interest.
2PE Fluorescence Lifetime Imaging
The ﬂuorescence lifetime of OGB1 and its Ca2+-dependent
changes (Agronskaia et al. 2004; Zheng et al. 2015) were measured
to obtain more quantitative information about the effect of HS
removal on pyramidal cell Ca2+ signaling. Time-correlated single
photon counting (TCSPC) was performed on a FV10MP Olympus
microscope upgraded with a TCSPC module (Picoquant). OGB1
lifetimes were quantiﬁed using a photon count ratio (see
Supplementary Fig. 3a for an illustration) and calibrated. Spatially
and temporally resolved lifetime analysis was performed on
frame scan and line scan data using custom written scripts
(Matlab, Mathworks). OGB1 lifetime changes were monitored dur-
ing 3 depolarizing voltage steps from −70 to +20mV; step dura-
tions were either 25 or 400ms, repeated at 1Hz. Line scans were
Figure 6. Intrahippocampal heparinase 1 injection impairs context discrimination in CFC. (a) Experimental design of CFC with injection of either active heparinase
(heparinase) or heat-inactivated heparinase (control) 24 h before CFC. (b) The group of mice injected with heparinase showed normal level of freezing in a neutral con-
text (CC−) before CFC on d0, and in the conditioned context (CC+) after CFC on d1 and d3. However, they were unable to discriminate the conditioned context (CC+,
solid bars) from the unconditioned, neutral one (CC−, empty bars). (c) The discrimination ratio (%) of freezing in the 2 different contexts (at the left panel) after con-
trol/heparinase injection conﬁrms the inability of mice to discriminate 2 different but similar contexts after HSs were removed by heparinase injection into the dorsal
hippocampus.
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repeated up to 6 times. To increase photon yield, TCSPC was per-
formed during both scanning and retracing. Photon arrival times
relative to the excitation pulse were accumulated over 20ms
bins, analyzed and subsequently converted into [Ca2+] (Fig. 3d).
Resting [Ca2+] presented in Supplementary Figure 5d was taken as
a mean of the baseline period.
Statistics
Numerical data are reported as mean ± SEM with n being the
number of samples. In ﬁgures, asterisks indicate statistical sig-
niﬁcance (details in ﬁgure or ﬁgure legend). Student’s t-tests and
multiway ANOVA with suitable post-hoc tests were used as
indicated and performed in Matlab (Mathworks), SPSS (IBM), and
Origin (OriginLab) and P represents the level of signiﬁcance.
Signiﬁcance levels are indicated in ﬁgures by asterisks (*P < 0.05,
**P < 0.01, ***P < 0.001) unless stated otherwise.
Results
Removal of HSs Impairs LTP
HSPGs can interact with a plethora of cellular components and
thereby modify synaptic transmission and plasticity. We ﬁrst
tested if enzymatic digestion of HSs affects synaptic transmission
and its LTP. HSs were removed from acute slices by incubating
slices in extracellular solution containing either heparinase 1
(1 U/mL) or heat-inactivated heparinase 1 (control treatment).
This protocol was sufﬁcient to cleave HSs in dissociated cultures
and acute hippocampal slices (see Supplementary Fig. 1). We next
tested if heparinase treatment affects excitatory synaptic trans-
mission. This was investigated at CA3–CA1 Schaffer collateral
synapses using ﬁeld potential recordings (fEPSPs) (see Fig. 1a–c,
Supplementary Fig. 2). To account for variable efﬁcacy of axonal
stimulation between slices and treatments, fEPSP slopes were
normalized to the amplitude of the axonal ﬁber volley. No effect
of heparinase treatment on fEPSPs could be detected over a range
of stimulation intensities (see Fig. 1b, Supplementary Fig. 2a–c).
Similarly, heparinase treatment did not affect NMDAR-mediated
fEPSPs (see Fig. 1b and Supplementary Fig. 2d). A potential modu-
lation of the presynaptic release probability by heparinase treat-
ment was assessed by paired-pulse stimulation experiments.
Again, no effect of heparinase treatment could be detected (see
Fig. 1c, Supplementary Fig. 2e,f). Together, these observations
indicate that heparinase treatment does not have a major impact
on baseline excitatory transmission at this synaptic pathway. We
next investigated LTP of synaptic transmission, because cleaving
hyaluronic acid, another glycan, was previously shown to impair
LTP at this synapse (Kochlamazashvili et al. 2010). LTP was
induced by a single cycle or repeated TBS (Fig. 1d,e). We found no
signiﬁcant effect of heparinase treatment on LTP induced by a
single cycle of TBS. However, when 5 cycles of TBSwere delivered,
an impairment of LTP in heparinase-treated slices was uncovered
(Fig. 1d,e). LTP in slices receiving the control treatment (heat-inac-
tivated heparinase) was not statistically different from native
slices, which were not incubated (native 156.1 ± 5.9% vs. heat-
inactivated heparinase 144.5 ± 4.8%, n = 8 both groups, P = 0.15,
unpaired t-test). The reduction of LTP in heparinase-treated slices
was not due to an effect on GABAergic synaptic inhibition,
because the reduction persisted in the presence of the ionotropic
GABA receptor inhibitor PTX (Fig. 1e). Together these results
reveal a signiﬁcant reduction of LTP induced by repeated TBS
after removal of HSs without an effect on baseline excitatory
transmission.
Impairment of Ca2+ Inﬂux During LTP Induction
The dependence of LTP on postsynaptic intracellular Ca2+ signal-
ing is well-established (Lynch et al. 1983). Therefore, we tested if a
reduced Ca2+ entry during LTP induction underlies the LTP impair-
ment observed after heparinase treatment. To this end, 2PE Ca2+
imaging was performed in spines and dendrites of CA1 pyramidal
cells held in the whole-cell patch-clamp conﬁguration (Ca2+ indi-
cator Fluo-4, Materials and Methods) during TBS of CA3–CA1
Schaffer collateral synapses (Fig. 2). In order to decrease interex-
periment variability, the intensity of axonal stimulation was set to
4× the current required for a single action potential to occur during
a single test burst of 5 stimuli (control 71.6 ± 5.9 µA, heparinase
55.2 ± 6.2 µA, n = 11 both groups, P = 0.19, unpaired t-test, see also
Kochlamazashvili et al. 2010) and NMDARs were inhibited by AP5
(NMDAR-dependent synaptic transmission was not affected by
heparinase, see above and Materials and Methods). Indeed, the
Ca2+-dependent ﬂuorescence transients evoked by TBS were redu-
ced in heparinase-treated slices (Fig. 2d). This was not a consequ-
ence of indicator saturation, because a 2.5-fold higher stimulus
intensity induced Fluo-4 ﬂuorescence transients with 3–4-fold hi-
gher amplitudes (P = 0.019 and <0.001 for control and heparinase-
treated slices, n = 4 and 6, unpaired t-tests). Thus, postsynaptic
Ca2+ signals during TBS are reduced in heparinase-treated slices
and this reduction is likely to underlie the observed reduction of
LTP. Importantly, boosting Ca2+ entry during induction of LTP
via L-type voltage-gated Ca2+ channels using BayK 8644 (15 µM)
abolishes the effect of heparinase treatment on LTP (control +
BayK 154.2 ± 6.6%, heparinase + BayK 151.6 ± 5.9, n = 8 both
groups, unpaired t-test, P = 0.77). While this observation does
not implicate L-type voltage-dependent Ca2+ channels (VGCCs)
in the heparinase-induced reduction of Ca2+ entry during TBS, it
demonstrates that the reduced Ca2+ entry is sufﬁcient to explain
the LTP deﬁcit in heparinase-treated slices.
No Change of Depolarization-Induced Ca2+ Entry
To identify the mechanism underlying reduced Ca2+ entry dur-
ing TBS, we further investigated how removal of HSs modiﬁes
Ca2+ signaling of CA1 pyramidal cells. VGCCs represent a main
route of Ca2+ entry at spines and dendrites. We previously
showed that hyaluronic acid, another component of the ECM,
supports Ca2+ entry via L-type VGCCs and in turn LTP
(Kochlamazashvili et al. 2010). Also, HSs can directly interact
with L-type VGCC and thereby delay channel inactivation in
HEK cells (Garau et al. 2015). Both observations suggest that
removal of HSs from hippocampal slices could impair L-type
channel function and thereby Ca2+ entry during TBS. This was
tested by recording Ca2+ responses to trains of back-propagating
action potentials (b-APs, 5 at 20Hz, Fig. 3). However, no effect of
heparinase treatment could be detected (Fig. 3c, n = 16 and 25
for control and heparinase treatment, 3-way repeated measures
ANOVA, P = 0.97) irrespective of whether Ca2+ transients were
recorded from spines or dendrites (P = 0.79).
Because dendritic APs could change their amplitude or width
uncontrollably when propagating toward the recorded spines
and dendrites, we also tested if Ca2+ responses evoked by som-
atic depolarization in voltage clamp are affected by heparinase
treatment in the presence of the sodium channel blocker TTX
and receptors antagonists (NBQX, AP5, PTX, CGP52432). To
obtain a more quantitative estimate of Ca2+ concentrations and
their changes, we used the Ca2+-dependent ﬂuorescence life-
time of OGB1 as a readout of Ca2+ concentrations (ﬂuorescence
lifetime imaging, FLIM [Agronskaia et al. 2004; Zheng et al.
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2015], Supplementary Fig. 3). Somatic voltage steps from −70 to
+20mV for 25ms triggered clearly detectable Ca2+ responses in
spines and dendrites (see Fig. 3d, Supplementary Fig. 3c,d),
which were not affected by dye saturation (see Supplementary
Fig. 3c,d). Again, amplitudes of Ca2+ responses were not affected
by heparinase treatment in spines or dendrites (Fig. 3d). How-
ever, a HS-dependent change of L-type VGCC inactivation may
not be detectable during brief depolarizations. Therefore, a sep-
arate set of experiments using the low-afﬁnity indicator Oregon
Green 488 BAPTA 6F (OGB6F) with long depolarization was per-
formed (see Supplementary Fig. 4). None of these experiments
including pharmacological tests with the L-type VGCC inhibitor
nifedipine suggested a modiﬁed behavior of VGCCs after hepari-
nase treatment. Finally, the resting Ca2+ concentration of den-
drites and spines was not different between heparinase and
sham treated slices (see Supplementary Fig. 5). Thus, the
impaired Ca2+ entry during TBS observed in slices after hepari-
nase incubation is not caused by a reduced availability or activ-
ity of VGCC channels.
Heparinase Treatment Reduces Pyramidal Cell
Excitability
The absence of an effect of heparinase treatment on Ca2+ entry
induced by somatic voltage step commands and b-APs promp-
ted us to explore if the decreased Ca2+ inﬂux during TBS could
be a consequence of reduced action potential ﬁring of pyram-
idal cells. To address this, the number of action potentials ﬁred
by pyramidal cells during TBS was analyzed for each burst dur-
ing TBS (Fig. 4a,b). This analysis revealed a signiﬁcant reduction
of spikes generated per burst when HSs had been removed by
heparinase treatment (Fig. 4b). Such a decrease of spikes ﬁred
per burst can have its origin upstream of the soma and axon,
for example a dampened dendritic integration of synaptic
input, or at the site of action potential generation itself, for
example reduced excitability of the AIS. To differentiate
between the 2 scenarios, 40ms long current pulses mimicking
the TBS pattern were injected into CA1 pyramidal cells (Fig. 4c).
Similar to synaptic TBS, the current pulse amplitude was set in
each individual neuron to 4× the current required for a single
spike upon a single current injection (no difference of currents
between treatments, Supplementary Fig. 7d). Analysis of the
average spike number per burst revealed a signiﬁcant reduction
of spiking in heparinase-treated slices, which was similar to
that observed during synaptic TBS (Fig. 4c,d). This heparinase-
induced reduction of pyramidal cell excitability is sufﬁcient to
explain the lower number of spikes generated during synaptic
TBS in heparinase-treated slices, and also the reduced Ca2+
entry and LTP. Having already excluded an effect of heparinase
treatment on synaptic transmission, this result also strongly
suggests that removal of HSs is affecting spike generation in the
AIS. One indicator of axonal excitability is the spike threshold
(Scott et al. 2014), which was therefore analyzed. Indeed, we
found that the second but not the ﬁrst spike threshold was
increased by heparinase treatment (Fig. 4e). This increase of the
spike threshold became prominent during later bursts, matching
the progressive reduction of spike numbers per burst (Fig. 4d). An
axonal site of action of heparinase is also indirectly suggested by
the absence of a heparinase effect on various other cell para-
meters. The peak spike voltage and maximum rate of depolariza-
tion represent indicators of somatic sodium channel availability.
Neither was affected by heparinase treatment (see Supplementary
Fig. 6). Also, no effect on the somatic membrane potential, the input
resistance, the IH-dependent sag potential, the spike width or the
medium after hyperpolarization was found (see Supplementary
Figure Legend 6 and Supplementary Fig. 7).
To gain further insight into the mechanism of heparinase
action, action potential trains were evoked by longer-lasting
current injections of increasing amplitude (Fig. 4f, left panel).
Again, a spike threshold increase was observed in heparinase-
treated slices (Fig. 4f, right panel). However, the effect on the
spike threshold became prominent only when stronger stimuli
were used. This is in line with 2 previous observations in our
present study. First, the current threshold for triggering a single
spike within 40ms (or 300ms) of stimulus onset is not affected
by removal of HSs (see Supplementary Fig. 7d). Second, stronger
stimuli with a TBS pattern do reveal the reduced excitability
(see above, Fig. 4a–d). Thus, the experimental evidence suggests
a role of HSs for maintaining spiking in response to strong
input at the AIS.
We, therefore, tested if heparinase treatment modiﬁes the
AIS. The protein AnkG is the master organizer of the AIS
(Yoshimura and Rasband 2014). Its axonal distribution indicates
the position and length of the AIS and changes of AnkG label-
ing accompany structural changes of the AIS, which affect
properties of action potential ﬁring such as the current thresh-
old and repetitive ﬁring (Grubb and Burrone 2010; Yoshimura
and Rasband 2014). Immunohistochemistry using an antibody
against AnkG was performed on dissociated hippocampal cul-
tures that received either a control or heparinase treatment
(see Supplementary Fig. 8). We found that heparinase treat-
ment selectively reduced the distal but not proximal AnkG
label, which indicates that the integrity of distal AIS is reduced
while the distance from the soma to the AIS start is not
affected after digestions of HSs. To conﬁrm these results in
acute slices, we used heparinase-treated and control slices
obtained from Thy1-YFP transgenic mice, in which a subset of
CA1 pyramidal cells express the ﬂuorescent protein YFP
(Fig. 5a). The distance from the AIS start to the soma-hillock
transition was analyzed ﬁrst (blinded to experimental condi-
tion). The start of the AIS was visually identiﬁed as the region
where AnkG labeling displayed a sharp rise. Its distance to the
soma-hillock transition was not affected by heparinase treat-
ment (control 4.6 ± 0.26 µm, n = 135; heparinase 4.7 ± 0.23 µm,
n = 154; P = 0.74, unpaired t-test), which is in agreement with
our observations in dissociated cultures. However, we noted a
considerable variability of the AIS start (see Supplementary
Fig. 9, coefﬁcient of variation >0.6 both groups) and also of the
trajectories of axons in all 3 dimensions. Therefore, we selected
only axons for further analysis that stayed within 5 µm of the
focal plane containing the axonal hillock (along the z-axis, to
avoid errors introduced by depth-dependent changes of ﬂuoro-
phore excitation and emission) and that had their AIS start
within mean ± 3 × SEM. Seventeen axons from control and 21
from heparinase-treated slices fulﬁlled these criteria and their
axonal AnkG proﬁles were averaged (Fig. 5b,c). As predicted by
experiments in dissociated cultures, the distal but not proximal
axonal AnkG label was signiﬁcantly reduced by heparinase
treatment (Fig. 5d,e). This indicates that, indeed, HSs have a
role in maintaining the AIS.
In previous work (Scott et al. 2014), we have demonstrated
that repetitive ﬁring expands the initially proximal and narrow
action potential initiation site further into the axon of DG
granular cells. A reduced integrity of the distal AIS after hepari-
nase treatment is, therefore, expected to selectively affect later
spikes during repetitive ﬁring, which is in good agreement with
the experimentally observed spiking behavior after heparinase
treatment (Fig. 4).
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Impairment of CFC
We next asked what the behavioral relevance of the LTP deﬁcit
after heparinase treatment might be. Selective impairment of
LTP induced by strong stimuli at CA3–CA1 synapses has previ-
ously been associated with a deﬁcit in CFC (Kochlamazashvili
et al. 2010) or context discrimination (Jin et al. 2013). Therefore,
we tested if heparinase treatment impairs fear conditioning or
context discrimination in a CFC paradigm (Fig. 6a, see Materials
and Methods). Injection of heparinase did not affect the level of
spontaneous freezing/immobility before CFC at d0 in the neu-
tral context (CC−) compared with control treatment (both con-
ditions ∼20% freezing, Fig. 6b). This level of freezing before CFC
is expected because mouse movement could be slightly con-
strained by the cable connection to the recording system (typ-
ical freezing level during fully unconstrained exploration of
novel environment is 5–10% in mice).
Of note, 48 and 96h after intrahippocampal heparinase injec-
tion, that is at d1 and d3, respectively, control- and heparinase-
injected mice showed similar freezing in the conditioned context
(CC+, Fig. 6b). Freezing times were 62.4 ± 5.7% (d1) and 57.6 ± 5.0%
(d3) in heparinase-injected mice (n = 9) and 67.1 ± 3.8% (d1) and
60.5 ± 3.9% (d3) after control treatment (n = 10, repeated measures
2-way ANOVA: treatments P = 0.507, days P = 0.103). However,
the freezing time in neutral contexts (CC−) was signiﬁcantly dif-
ferent (P = 0.0093) between treatment groups and the test day
was a signiﬁcant factor (P = 0.031). Heparinase-injected mice froze
in CC− as long as in CC+ (61.4 ± 4.7% and 53.3 ± 4.6% at d1 and
d3, respectively) whereas the control group froze in CC− less than
in CC+ (43.9 ± 4.5% and 39.1 ± 3.3% at d1 and d3, respectively;
CC+ vs. CC− in the control group P < 0.001 at both days; CC+ vs.
CC− in heparinase-injected animals P > 0.3 at both days; paired
t-tests). We, therefore, calculated the context discrimination
ratio ([Freezing% in CC+] − [Freezing% in CC−])/ ([Freezing% in
CC+] + [Freezing% in CC−]), which revealed the inability of
heparinase-injected mice to discriminate between the condi-
tioned context CC+ and the unconditioned neutral CC− at any
testing days (Fig. 6c), unlike control mice (P < 0.005 at d1 and P <
0.01 at d3).
Reduction of Oscillatory Network Activity In Vivo
by Heparinase Treatment
In vivo, hippocampal neuronal activity can be synchronized in
different frequency bands depending on the behavioral state.
These hippocampal oscillations, in particular those at the theta
frequency range, are implicated in many learning and memory
processes in humans and animals (Colgin 2016). Therefore, we
explored how low theta (Lθ, 4–7Hz) and high theta (Hθ, 7–10Hz)
oscillations during CFC are affected by context, behavior and
heparinase treatment (Fig. 7). Frequency analysis in the θ range
revealed that when mice were actively exploring their environ-
ment, theta activity peaked in Hθ. However, when mice were
freezing, independent of context, theta peak activity was
shifted to Lθ (Fig. 7a–d). This shift was highly signiﬁcant in both
treatment groups (P < 0.0005) and was stable over time. The
θ peak frequency during freezing (fr) events stayed within Lθ
range around 6Hz (5.8 ± 0.4 − 7 ± 0.4 Hz) for both treatment
groups and recording areas (CA1 stratum pyramidale and DG
stratum moleculare, Fig. 7e). Similarly, the θ peak frequency dur-
ing exploration (exp) was mostly in the Hθ band ranging from
7.9 ± 0.2 to 9.1 ± 0.2 Hz (Fig. 7e).
Statistical analysis (general linear model with repeated mea-
sures; 4 within-subject factors: context, behavior, day after CFC,
brain region; one between-subject factor: heparinase/control
treatment) showed that only one factor, behavior (freezing ver-
sus exploration), highly signiﬁcantly (P < 0.0005) modulated the θ
frequency at d1 and d3. Furthermore, there were signiﬁcant
interactions between treatment and context (P = 0.003), as well
as between treatment and day (P = 0.009). At d0, only data
recorded in the CC− context were available for analysis of the θ
frequency shift by design (Fig. 7e, left panel). To compare θ fre-
quency shifts over the entire duration of the CFC experiments,
another analysis was performed using only data obtained in CC−
but from d0, d1, and d3. Again, analysis showed that only behav-
ior (P < 0.0005) modulated the θ frequency. In addition, we found
interactions between treatment and day (P = 0.023) as well as
between day and behavior (P = 0.006) probably reﬂecting the fact
that at d0 the peak Hθ (~9Hz) was slightly higher compared with
d1 and d3 (~8Hz). To conclude, neither heparinase treatment nor
context alone inﬂuenced the main θ frequency during explora-
tory and freezing behavior in mice.
We next tested if the degree of network synchronization is
affected by heparinase treatment. Spectral power is a useful
measure of synchronization of neuronal activity near the
recording electrode. To compare the power of Lθ oscillations (4–
7Hz) during freezing versus exploration events, we normalized
Lθ power during freezing over Lθ power during exploration in
both contexts (CC+/CC−). We found that Lθ power doubled dur-
ing freezing in CC+ at d1/d3, without an effect of heparinase
treatment (Fig. 7f). However, statistical analysis based on the
general linear model with repeated measures indicated a sig-
niﬁcant interaction between context and treatment at d1 and
d3 (P = 0.003). This reﬂects that in control mice the relative Lθ
power in CC+ during freezing tended to be higher than in CC−,
whereas in the heparinase-treated group the relative Lθ power
in CC− during freezing tended to be higher compared with CC+.
This correlates well with a higher freezing of heparinase-
injected mice in CC− and the loss of contextual discrimination
after heparinase injection. Also, the relative Lθ power was dif-
ferent between treatment groups at d1 in CC− (DG only,
repeated measures 2-way ANOVA, P < 0.05).
Finally, we investigated Lθ power changes during CFC in
heparinase-injected animals and control animals (Fig. 7g,h). There
was no difference between treatment groups in Lθ during baseline
recordings. However, the control group showed a 2-fold increase
of Lθ power at post-training days d1 and d3 in both CC+ and CC−
contexts (Fig. 7g) compared with the baseline preconditioning
level at d0. In contrast, the network activity in the Lθ band of
heparinase-injected animals was not elevated after CFC. Instead,
the power of Lθ oscillations after CFC was almost unaffected at d1
and slightly elevated at d3 compared with the baseline period
before CFC (Fig. 7g,h). Analysis revealed no strongly signiﬁcant
effect of context (P = 0.07) or brain region (P = 0.071). However,
several other parameters signiﬁcantly contributed to the Lθ
changes: day (P = 0.01), brain region and day (P = 0.023) as well as
heparinase treatment (P = 0.016).
Thus, the heparinase-induced impairment of context dis-
crimination in CFC is associated with 2 distinct effects on theta
oscillations. Heparinase injection affected the Lθ power increase
during freezing after CFC in a context-dependent manner and
prevented the post-CFC increase of Lθ power.
Discussion
The acute contribution of HSs to hippocampal function was
identiﬁed in vitro and in vivo by enzymatic digestion of HSs.
We found a distinct deﬁcit of LTP of CA3–CA1 Schaffer
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Figure 7. Theta oscillations during CFC aremodiﬁed by intrahippocampal heparinase injection. (a) Schematic of surgical implantation of hippocampal electrodes and cannulas
into a mouse brain with given coordinates and speciﬁc arrangement for a HIME system (Senkov et al. 2015). (b) Nissl staining of a brain sectionwith located electrode tracks at
the right dorsal hippocampus depicting the tips of the deepest electrodes at the DG and themost superﬁcial electrodes at pyramidal cell layer of CA1. (c) Representative epochs
of LFPs in both recorded areas (CA1 and DG) and in both treatment groups showing high theta oscillations (Hθ: 7–10Hz) while mice explore the conditioned context (CC+) and
low theta (Lθ: 4–7Hz) when they freeze. (d) Representative examples of spectrograms of low frequency oscillations (2–20Hz) in CC+ for 5min at d1 after heparinase or control
injection. Low theta oscillations show high power speciﬁcally at freezing events, while high theta appears only during exploration/motion epochs. Heparinase-injected mice
show a reduction in power of low theta oscillations during retrieval of CFCmemory traces versus control. (e) Analysis of θ peak frequency over all recording days shows a θ fre-
quency shift from Hθ (7–10Hz) to Lθ (4–7Hz) of both treatment groups whenmice explore (exp) either context (CC+/CC−) and freeze (fr). (f) Analysis of relative Lθ power during
freezing normalized over Lθ power during exploration behavior shows a distinct increase (∼100%) of Lθ power during freezing in CC+ and a lower increase in CC− in control
mice. In heparinase-injected animals, a qualitatively opposite effect was detected, that is Lθ power increased in CC− during freezing more than in CC+. (g, h) The averaged low
(4–7Hz) theta power after CFCwas normalized to the prefear conditioning level (baseline, B). A prominent increase of Lθ power can be detected after CFC in control experiments
but not in heparinase-injected animals (sample traces in h; * signiﬁcant difference of theta power in CC+ contexts between 2 treatment groups; +, ++, +++ signiﬁcant difference
of theta power in CC− contexts between 2 treatment groups).
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collateral synapses after removal of HSs when a strong LTP-
inducing paradigm was used in vitro. A reduced Ca2+ entry dur-
ing LTP induction was identiﬁed as the underlying mechanism.
This was not caused by alterations of excitatory or inhibitory
synaptic transmission, but by a reduced axonal excitability of
CA1 pyramidal cells. In vivo, removal of HSs was accompanied
by a loss of context discrimination and abnormalities in Lθ
oscillations.
HSs Regulate LTP and CA1 Pyramidal Cell Excitability
Previous studies have implicated HSPGs as contributors to syn-
aptic plasticity. For instance, genetic deletion of the HSPG
syndecan-3 improved LTP of CA3–CA1 synapses (Kaksonen
et al. 2002). In contrast, enzymatic removal of HSs using hepari-
nase 3 decreased LTP at the same pathway (Lauri et al. 1999),
but the cellular mechanism has remained unclear.
We now demonstrate that speciﬁc removal of highly sulfated
HSs with heparinase 1 results in impaired LTP that is only
detected when strong LTP-inducing stimuli are used. This was
not the consequence of altered baseline excitatory synaptic
transmission at CA3–CA1 synapses, in line with a previous study
(Lauri et al. 1999). Instead, we observed a reduction of Ca2+ inﬂux
during LTP induction in HSs deﬁcient hippocampal slices. This
reduced Ca2+ inﬂux is sufﬁcient to explain the LTP deﬁcit,
because pharmacological boosting of Ca2+-entry using the L-type
VGCC modulator BayK 8644 was sufﬁcient to restore LTP. At the
surface, these functional consequences of HSs removal are simi-
lar to observations after digestion of hyaluronic acid (Kochlama-
zashvili et al. 2010). In both cases, a reduced Ca2+ inﬂux during
LTP induction and decreased LTP was observed. However, mech-
anistically both ECM components control LTP differently.
Hyaluronic acid is required for maintenance of somatodendritic
L-type VGCC function in hippocampal neurons. In contrast, HSs
do not appear to affect L-type VGCCs at these cells but rather
support axonal excitability. Several experimental ﬁndings are in
line with this conclusion.
First, no modulation of Ca2+ entry in response to b-APs or
direct depolarization was detected using electrophysiology in
combination with intensity and lifetime-based Ca2+ imaging.
Therefore, an altered function of somatodendritic VGCCs at
CA1 pyramidal cells cannot explain the decreased Ca2+ entry
after heparinase treatment. This appears to be at odds with
experiments in HEK293 cell transfected with L-type VGCC, in
which HSs modulated voltage-dependent inactivation of Ba2+
currents (Garau et al. 2015). However, these culture experiments
were done in the absence of Ca2+, which was not the case in pre-
sent experiments even though they were performed in the pres-
ence of high-afﬁnity Ca2+ indicators. Therefore, Ca2+-dependent
inactivation in the present experiments may mask the voltage-
dependent effects of heparinase treatment on VGCC function
found in cultures. Thus, in physiological settings, that is with
fully intact intracellular Ca2+ signaling, a direct modulation of
VGCCs by HSs is likely to play a minor role. Second, the number
of action potentials ﬁred by CA1 pyramidal cells during LTP
induction was signiﬁcantly reduced in heparinase-treated slices
and this effect could be reproduced by strong somatic current
injections. Because the action potential-induced Ca2+ entry is
not different between control and heparinase-treated slices, the
reduced number of action potentials during LTP induction in
heparinase-treated slices explains the decrease of Ca2+ entry
during LTP induction. A plausible cause of reduced spiking is the
increased threshold of action potentials in heparinase-treated
slices. This increase of the spike threshold did only become
apparent during TBS-like and strong current injections (Fig. 4e,f,
see also Supplementary Figure Legend 7). Also, it was not accom-
panied by changes of the somatic spike waveform, which would
have suggested an involvement of somatic sodium channel
inactivation or other mechanisms that would alter somatic
sodium channel density/availability. In addition, none of the
parameters of CA1 pyramidal cell excitability that were moni-
tored at the soma were affected by heparinase treatment. Thus,
a selective modulation of axonal excitability or action potential
initiation by HSs represents the most parsimonious explanation
of our electrophysiological observations.
The AIS is the site of action potential generation. Its geometry,
location, and the distribution and availability of its ion channels
dynamically determine the site and threshold of spike initiation
(Kole and Stuart 2012; Yoshimura and Rasband 2014). AnkG is a
key organizing molecule of the AIS and important for ion channel
clustering at the AIS and thus sets key parameters of neuronal
spiking (Grubb and Burrone 2010; Kole and Stuart 2012;
Yoshimura and Rasband 2014). In our experiments, heparinase
treatment selectively reduced the distal but not proximal axonal
density of AnkG. Given the importance of AnkG in orchestrating
the clustering of ion channels in the AIS, the reduced presence of
AnkG is expected to profoundly impair ion channel clustering in
the distal AIS after heparinase treatment. Interestingly, we have
previously observed in DG granular cell axons that the action
potential initiation site is initially proximal and narrow but
widens and extends further into the axon during repetitive spik-
ing (Scott et al. 2014). This indicates that the impairment of the
distal AISmay onlymanifest during repetitive spiking, which is in
good agreement with our experimental observations. Thus, HSs
helpmaintain distal AIS integrity and as a consequence repetitive
spiking. This could involve changes of, for instance, sodium or
potassium channel density in the distal AIS.
Interestingly, the HSPG perlecan is recruited by dystroglycan
to nodes of Ranvier, where it binds gliomedin and enhances
clustering of node of Ranvier components (Colombelli et al.
2015). Although perlecan may play a more prominent role in
organizing the AIS in the peripheral nervous system (Colombelli
et al. 2015), all major HSPGs including perlecan are expressed in
the hippocampus (Karthikeyan et al. 1994; Shee et al. 1998; Lauri
et al. 1999). Moreover, NrCam and Neurofascin-186 are 2 mole-
cules that establish a link between the ECM and AnkG and are
thus thought to contribute to sodium and potassium channels
clustering (Nav1.x, Kv1, and Kv7 families) (Dityatev et al. 2010;
Rasband 2010). In addition, other components of the ECM like
tenascins may also affect sodium channel clustering/activity in
the AIS (Srinivasan et al. 1998). To summarize, the most likely
scenario is that heparinase treatment disrupts the AIS ECM and
modiﬁes distal AnkG levels and ion channel clustering. A num-
ber of interesting questions for future work emerge from our
ﬁndings. For instance, it remains to be shown that removal of
HSs speciﬁcally at the AIS is responsible for the observed effects.
It will also be interesting to dissect if the observed reduction of
AIS excitability is primarily caused by a reduction of distal AIS
potassium or sodium channels clustering or both. In addition, it
remains to be established, if the impairment of LTP and neur-
onal excitability after HS removal are speciﬁc to the CA1 region
or a ubiquitous effect.
Previous studies revealed the importance of interaction
between HSPG syndecan-3—heparin-binding growth-associated
protein (HB-GAM or pleiotrophin) in synaptic plasticity (Lauri
et al. 1999; Kaksonen et al. 2002; Pavlov et al. 2002). However,
mice deﬁcient in syndecan-3 exhibited enhanced rather than
reduced LTP (Kaksonen et al. 2002), and hence do not mimic the
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effect of heparinase 1. Moreover, syndecan-3 seems to act via
postsynaptic mechanisms rather than by inﬂuencing axonal
excitability (Lauri et al. 1999; Melendez-Vasquez et al. 2005). Thus,
our experiments revealed a novel function of HSs in neuronal
excitability and LTP that is mediated by proteoglycans carrying
highly sulfated HSs. The speciﬁc effects observed after hepari-
nase 1 treatment may be related to a loss of speciﬁc glycoepitopes
or to the generation of novel molecular recognitions sites with
a terminal glucosamine, which are distinct from N-acetyl-
glucosamine-containing sites generated by heparinase 3.
HSs Support Learning and Learning-Related Network
Oscillations
Our data provide the ﬁrst evidence that a speciﬁc and acute
modiﬁcation of HSs in the adult brain, that is cleavage of highly
sulfated HSs in the hippocampus, can lead to impairment of
context discrimination, but not learning per se. A similar com-
bination of an impairment of context discrimination and modi-
ﬁed LTP in the CA1 region in vitro has also been observed in
other studies. For instance, inhibition of the Ras-GRF1 pathway
in the CA1 region modulated LTP and context discrimination
(Jin et al. 2013; Darcy et al. 2014). Thus, the present study
uncovers a contribution of HSs for hippocampal LTP and con-
text discrimination and also supports the notion that the CA1
region is involved in context discrimination (Place et al. 2012;
Czerniawski and Guzowski 2014).
We also uncovered several interesting relationships between
hippocampal θ oscillations, behavior, and removal of highly sul-
fated HSs by heparinase. First, the transition from exploration to
freezing was accompanied by a shift from high to low θ oscilla-
tions independently of treatment. A similar Hθ to Lθ shift was
ﬁrst described by Seidenbecher et al. (2003), who provided exam-
ples illustrating that theta activity between 7 and 10Hz prevails
in the CA1 during risk-assessment behavior, and θ activity
between 4 and 5Hz appears in the lateral amygdala and CA1
during freezing. Qualitatively similar observations have been
documented in various other studies (Machado et al. 2012;
Ognjanovski et al. 2014; Tendler and Wagner 2015). Thus, a high
to low theta frequency shift is strongly associated with freezing
behavior. However, this relationship was not profoundly affected
by removal of highly sulfated HSs and does, therefore, not
explain the impaired context discrimination after heparinase
injection.
In contrast, we found that fear conditioning increased the
power of Lθ oscillations in control but much less in heparinase-
injected animals. This effect was particularly prominent in the
CA1 region and correlated well with the impaired excitability
and LTP in the same region in vitro. It is intuitive that a
reduced excitability of pyramidal cells reduces the power of
network oscillations. For instance, recordings from mice with
reduced activity of Nav1.6, a sodium channel enriched at the
AIS, and nodes of Ranvier display a reduction of the θ power in
awake animals (Pal et al. 2015).
This absence of a Lθ oscillations power increase after CFC in
heparinase-injected animals was associated with impaired
context discrimination. The most parsimonious explanation for
these ﬁndings is that an Lθ oscillations power increase is
required for successful context discrimination in CFC. Indeed,
available data suggest that CA1 Lθ power is a predictor for suc-
cessful fear-driven memory retrieval in rodents. For instance,
the muscarinic cholinergic antagonist scopolamine disrupts
CFC (Anagnostaras et al. 1999) whereas M1/M4 agonists
improve CFC in aged mice (Si et al. 2010). At the same time,
cholinergic innervation powerfully modulates hippocampal
theta oscillation power and coherence (Hasselmo 2006;
Vandecasteele et al. 2014). Also, inactivation of the ventral teg-
mental area with procaine in rats leads to impaired fear condi-
tioning and decreased θ power of CA1 speciﬁcally at the Lθ
frequency range (3–6Hz) during immobility states, whereas
control rats exhibit an increases in θ power after fear condition-
ing (Matulewicz et al. 2015). Therefore, we speculate that inter-
fering with increase of Lθ may impair learning and/or retrieval
of context memories or, as our data suggest, introduce an error
in discrimination of 2 similar but yet different contexts.
Conclusion
In this study, we have explored the contribution of highly
sulfated HSs to hippocampal function and behavior. Their
acute removal impairs synaptic LTP by lowering postsynaptic
axonal excitability in vitro. In vivo, we demonstrate a role of
HSs in modulating theta oscillation and context discrimin-
ation in a fear conditioning paradigm. It remains to be estab-
lished to what degree pyramidal cell excitability alone
explains our in vivo observation and if changes of, for
instance, interneuron function are involved too. Nonetheless,
our results demonstrate that HSs are continuously required
in the adult brain to maintain hippocampal plasticity and
hippocampus-dependent memory.
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